Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$14.99 - $32.65 $37,325 - $81,298
-2,490 Reduced 5.66%
41,518 $622,000
Q2 2023

Aug 11, 2023

SELL
$29.76 - $46.14 $193,737 - $300,371
-6,510 Reduced 12.89%
44,008 $1.43 Million
Q1 2023

May 10, 2023

BUY
$38.09 - $57.79 $386,880 - $586,973
10,157 Added 25.17%
50,518 $1.98 Million
Q4 2022

Feb 13, 2023

BUY
$40.54 - $56.2 $405,927 - $562,730
10,013 Added 32.99%
40,361 $2.13 Million
Q3 2022

Nov 10, 2022

BUY
$36.98 - $49.2 $188,413 - $250,674
5,095 Added 20.18%
30,348 $1.37 Million
Q2 2022

Aug 12, 2022

BUY
$28.03 - $45.8 $20,153 - $32,930
719 Added 2.93%
25,253 $918,000
Q1 2022

May 16, 2022

BUY
$29.24 - $44.06 $53,275 - $80,277
1,822 Added 8.02%
24,534 $1.01 Million
Q4 2021

Feb 14, 2022

SELL
$39.32 - $61.61 $64,995 - $101,841
-1,653 Reduced 6.78%
22,712 $967,000
Q3 2021

Nov 12, 2021

BUY
$44.0 - $65.8 $181,588 - $271,556
4,127 Added 20.39%
24,365 $1.34 Million
Q2 2021

Aug 16, 2021

SELL
$44.66 - $63.06 $248,086 - $350,298
-5,555 Reduced 21.54%
20,238 $968,000
Q1 2021

May 14, 2021

SELL
$46.31 - $62.7 $504,825 - $683,492
-10,901 Reduced 29.71%
25,793 $1.31 Million
Q4 2020

Feb 12, 2021

BUY
$55.51 - $69.94 $621,989 - $783,677
11,205 Added 43.96%
36,694 $2.31 Million
Q3 2020

Nov 13, 2020

SELL
$42.19 - $69.61 $34,764 - $57,358
-824 Reduced 3.13%
25,489 $1.71 Million
Q2 2020

Aug 12, 2020

BUY
$27.55 - $43.28 $439,312 - $690,142
15,946 Added 153.81%
26,313 $1.1 Million
Q1 2020

May 13, 2020

SELL
$23.16 - $47.8 $90,161 - $186,085
-3,893 Reduced 27.3%
10,367 $326,000
Q4 2019

Feb 12, 2020

SELL
$27.97 - $40.38 $366,127 - $528,574
-13,090 Reduced 47.86%
14,260 $575,000
Q3 2019

Nov 12, 2019

BUY
$31.65 - $46.94 $865,627 - $1.28 Million
27,350 New
27,350 $889,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.